CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
07/06/2023
Voltar para busca
Dado oficial do USPTO
STRAGEN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
STRAGEN
ST13
US500000079121314Classe
1, 5, 35, 42, 44, 45
Pedido
79121314
Registro
4449450
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
07/06/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 35, 42, 44, 45
Data de depósito
09/10/2012
Data de registro
17/12/2013
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/02/2021
Última transação
26/02/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
CH-1228 Plan-Les-Ouates, CH
Examinador
LOBO, DEBORAH
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Stragen Pharma S.A.
Representantes
Katzarov SA
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 35Classe 42Classe 44Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical preparations for industrial and scientific useincluding for diagnostic use; chemical reagents other than for medical or veterinary use; diagnostic preparationsother than for medical or veterinary use; chemical substancesreagents for chemical analysis in laboratories
Classe 5
Pharmaceutical preparations and substancesantibioticsanticonvulsantsantiepileptic preparations and substances for the treatment of cardiological diseasesbone diseasesoncologygynecologyrhumatologyphlebology and dermatological disorders and diseases; chemical reagents for medical and veterinary use; diagnostic preparations for medical and veterinary use
Classe 35
Administrative processing of applications for marketing release authorization and regulatory approval of pharmaceutical and medical products; electronic data collection and data submission services for commercial purposes provided in connection with clinical researchtestingtrials and finalization of pharmaceutical productsmedical devices and biotechnology
Classe 42
Consulting in the field of pharmaceutical science; researchdesign and development in the medical and pharmaceutical field; development of medicines for others; conducting clinical and preclinical trials and supervision of clinical and preclinical trials; development of medicines in compliance with regulatory requirements; conducting clinical trials for others in the field of medicine compatibility; pharmacovigilance services for othersmonitoring the quality and efficacy of pharmaceutical preparations; consultancy in the field of medical and pharmaceutical research; providing advice in connection with clinical trial researchtesting and evaluation of pharmaceutical productsmedical devices and biotechnology; evaluating medicines of others to assure compliance with regulatory requirements; providing data analysis of data obtained in connection with clinical trial research and testing of pharmaceutical productsmedical devices and biotechnology; scientific research relating to the evaluation of new medicines; development of pharmaceutical preparationsremedies and medicines; technological servicesscientific researchanalysis and testing in the pharmaceutical and health care sector; scientific research and analysisconducting early evaluations in the field of new pharmaceutical preparations; scientific research and development in the pharmaceutical field; scientific research and developmentconducting clinical trials of medicines of others; product development in the field of medicine
Classe 44
Consultancy in the field of medical treatments and advice in the pharmaceutical field
Classe 45
Regulatory compliance consultancy in the field of pharmaceutical productsmedical devices and biotechnology products
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
11/04/2023
FINP
FINAL DECISION TRANSACTION PROCESSED BY IB
05/04/2023
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
11/01/2023
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
11/01/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
11/01/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
01/11/2022
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
26/10/2021
C71T
CANCELLED SECTION 71
26/02/2021
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
08/05/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/03/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
13/06/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/05/2014
FIMP
FINAL DISPOSITION PROCESSED
09/05/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/03/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
17/12/2013
PUBO
PUBLISHED FOR OPPOSITION
01/10/2013
GPNX
NOTIFICATION PROCESSED BY IB
30/09/2013
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/09/2013
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/09/2013
NPUB
NOTICE OF PUBLICATION
11/09/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
27/08/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/08/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/08/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/08/2013
ALIE
ASSIGNED TO LIE
16/08/2013
NREV
NOTICE OF REVIVAL - MAILED
14/08/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/08/2013
PETG
PETITION TO REVIVE-GRANTED
14/08/2013
PROA
TEAS PETITION TO REVIVE RECEIVED
14/08/2013
ATRV
ATTORNEY REVIEW COMPLETED
10/05/2013
LIMS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
10/05/2013
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
20/04/2013
RFNT
REFUSAL PROCESSED BY IB
27/02/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/02/2013
RFRR
REFUSAL PROCESSED BY MPU
05/02/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/02/2013
CNRT
NON-FINAL ACTION WRITTEN
04/02/2013
DOCK
ASSIGNED TO EXAMINER
04/02/2013
MAFR
APPLICATION FILING RECEIPT MAILED
18/12/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/12/2012
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/12/2012
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace STRAGEN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.